European Pharmaceuticals 2019 - Plenty of noise in 2019: choose carefully
In these six short videos Liberum's Healthcare Analyst Graham Doyle looks at European Pharmaceuticals with a particular focus on US pricing, is the valuation of the sector attractive, do the earnings outlook and macro environment look favourable and his top and least preferred stocks. Click here to read the latest research. Click the image below to watch the videos.
This communication is for use only by a person or entity that qualifies as a "Professional Client" or "Eligible Counterparty" within the meaning of the FCA's rules. It is therefore intended for use only by persons having professional experience in matters relating to investments. Any other person who receives this should not act on the contents. Disclaimer here.